S A Berry1, J A Fleishman2, R D Moore1, K A Gebo1. 1. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD, USA.
Abstract
OBJECTIVES: Risk-adjusted 30-day hospital readmission rate is a commonly used benchmark for hospital quality of care and for Medicare reimbursement. Persons living with HIV (PLWH) may have high readmission rates. This study compared 30-day readmission rates by HIV status in a multi-state sample with planned subgroup comparisons by insurance and diagnostic categories. METHODS: Data for all acute care, nonmilitary hospitalizations in nine states in 2011 were obtained from the Healthcare Costs and Utilization Project. The primary outcome was readmission for any cause within 30 days of hospital discharge. Factors associated with readmission were evaluated using multivariate logistic regression. RESULTS: A total of 5 484 245 persons, including 33 556 (0.6%) PLWH, had a total of 6 441 695 index hospitalizations, including 45 382 (0.7%) among PLWH. Unadjusted readmission rates for hospitalizations of HIV-uninfected persons and PLWH were 11.2% [95% confidence interval (CI) 11.2, 11.2%] and 19.7% (95% CI 19.3, 20.0%), respectively. After adjustment for age, gender, race, insurance, and diagnostic category, HIV infection was associated with 1.50 (95% CI 1.46, 1.54) times higher odds of readmission. Predicted, adjusted readmission rates were higher for PLWH within every insurance category, including Medicaid [12.9% (95% CI 12.8, 13.0%) and 19.1% (95% CI 18.4, 19.7%) for HIV-uninfected persons and PLWH, respectively] and Medicare [13.2% (95% CI 13.1, 13.3%) and 18.0% (95% CI 17.4, 18.7%), respectively], and within every diagnostic category. CONCLUSIONS: HIV infection is associated with significantly increased readmission risk independent of demographics, insurance, and diagnostic category. The 19.7% 30-day readmission rate may serve as a preliminary benchmark for assessing quality of care of PLWH. Policy-makers may consider adjusting for HIV infection when calculating a hospital's expected readmission rate.
OBJECTIVES: Risk-adjusted 30-day hospital readmission rate is a commonly used benchmark for hospital quality of care and for Medicare reimbursement. Persons living with HIV (PLWH) may have high readmission rates. This study compared 30-day readmission rates by HIV status in a multi-state sample with planned subgroup comparisons by insurance and diagnostic categories. METHODS: Data for all acute care, nonmilitary hospitalizations in nine states in 2011 were obtained from the Healthcare Costs and Utilization Project. The primary outcome was readmission for any cause within 30 days of hospital discharge. Factors associated with readmission were evaluated using multivariate logistic regression. RESULTS: A total of 5 484 245 persons, including 33 556 (0.6%) PLWH, had a total of 6 441 695 index hospitalizations, including 45 382 (0.7%) among PLWH. Unadjusted readmission rates for hospitalizations of HIV-uninfectedpersons and PLWH were 11.2% [95% confidence interval (CI) 11.2, 11.2%] and 19.7% (95% CI 19.3, 20.0%), respectively. After adjustment for age, gender, race, insurance, and diagnostic category, HIV infection was associated with 1.50 (95% CI 1.46, 1.54) times higher odds of readmission. Predicted, adjusted readmission rates were higher for PLWH within every insurance category, including Medicaid [12.9% (95% CI 12.8, 13.0%) and 19.1% (95% CI 18.4, 19.7%) for HIV-uninfectedpersons and PLWH, respectively] and Medicare [13.2% (95% CI 13.1, 13.3%) and 18.0% (95% CI 17.4, 18.7%), respectively], and within every diagnostic category. CONCLUSIONS:HIV infection is associated with significantly increased readmission risk independent of demographics, insurance, and diagnostic category. The 19.7% 30-day readmission rate may serve as a preliminary benchmark for assessing quality of care of PLWH. Policy-makers may consider adjusting for HIV infection when calculating a hospital's expected readmission rate.
Authors: Kenneth A Lichtenstein; Carl Armon; Kate Buchacz; Joan S Chmiel; Kern Buckner; E M Tedaldi; Kathy Wood; Scott D Holmberg; John T Brooks Journal: Clin Infect Dis Date: 2010-08-15 Impact factor: 9.079
Authors: Stephen A Berry; John A Fleishman; Baligh R Yehia; P Todd Korthuis; Allison L Agwu; Richard D Moore; Kelly A Gebo Journal: AIDS Date: 2013-08-24 Impact factor: 4.177
Authors: Gita Suneja; Meredith S Shiels; Sharon K Melville; Melanie A Williams; Ramesh Rengan; Eric A Engels Journal: AIDS Date: 2013-01-28 Impact factor: 4.177
Authors: Janet M Blair; Jennifer L Fagan; Emma L Frazier; Ann Do; Heather Bradley; Eduardo E Valverde; Ad McNaghten; Linda Beer; Shuyan Zhang; Ping Huang; Christine L Mattson; Mark S Freedman; Christopher H Johnson; Catherine C Sanders; Kathryn E Spruit-McGoff; James D Heffelfinger; Jacek Skarbinski Journal: MMWR Suppl Date: 2014-06-20
Authors: Aida Bianco; Antonio Molè; Carmelo G A Nobile; Gabriella Di Giuseppe; Claudia Pileggi; Italo F Angelillo Journal: PLoS One Date: 2012-11-02 Impact factor: 3.240
Authors: Thibaut Davy-Mendez; Sonia Napravnik; David A Wohl; Amy L Durr; Oksana Zakharova; Claire E Farel; Joseph J Eron Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Lara E Coelho; Sayonara R Ribeiro; Andre M Japiassu; Ronaldo I Moreira; Priscila C Lara; Valdilea G Veloso; Beatriz Grinsztejn; Paula M Luz Journal: J Acquir Immune Defic Syndr Date: 2017-08-01 Impact factor: 3.731
Authors: Destani J Bizune; Russell R Kempker; Michelle Kagei; Aliya Yamin; Omar Mohamed; David P Holland; Alawode Oladele; Yun F Wang; Paulina A Rebolledo; Henry M Blumberg; Susan M Ray; Marcos C Schechter Journal: AIDS Res Hum Retroviruses Date: 2018-09-11 Impact factor: 2.205
Authors: Jeremy Y Chow; Ank E Nijhawan; W Christopher Mathews; Julia Raifman; Julia Fleming; Kelly A Gebo; Richard D Moore; Stephen A Berry Journal: J Acquir Immune Defic Syndr Date: 2021-06-01 Impact factor: 3.771
Authors: Sarah E Macinski; Jayleen K L Gunn; Mona Goyal; Charles Neighbors; Rajeev Yerneni; Bridget J Anderson Journal: Am J Epidemiol Date: 2020-05-05 Impact factor: 4.897
Authors: Kathleen M Akgün; Supriya Krishnan; Adeel A Butt; Cynthia L Gibert; Christopher J Graber; Laurence Huang; Margaret A Pisani; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Amy C Justice; Kristina Crothers; Janet P Tate Journal: AIDS Date: 2021-11-15 Impact factor: 4.177